HighTower Advisors »

Supernus Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $395k 14k 28.82
2023-09-30 $341k 13k 27.33
2023-03-31 $221k 6.0k 37.07
2022-12-31 $263k 7.2k 36.37
2020-06-30 $1.2M 51k 23.69
2018-09-30 $203k 4.0k 50.31
2018-06-30 $252k 4.2k 59.64
2016-09-30 $464k 19k 24.73
2016-03-31 $306k 20k 15.14
2015-12-31 $295k 22k 13.61